ARCHIVES

FDA Approves Lapatinib For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

NCI Begins TAILORx Study.

May 26, 2006

King Tells Centers To Concentrate On Project Grants

October 15, 1976

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995